tailieunhanh - Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma

Anti-PD-1 and BRAF-inhibitors (BRAFi) have been approved as first-line treatments in advanced melanoma. To date, no prospective data are available to give the best sequence of treatment. | Ineffective anti PD-1 therapy after BRAF inhibitor failure in advanced melanoma

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN